Neonatal transfer of membrane-bound stem cell factor improves survival and heart function in aged mice after myocardial ischemia

Human Gene Therapy

Volumn 23, Issue 12, 2012, Pages 1280-1289

  Sun, Zhuo ^a,b   Lee, Chyan Jang ^a   Mejia Guerrero, Salvador ^a   Zhang, Yuemei ^a,b   Higuchi, Koji ^a   Li, Ren Ke ^a,b   Medin, Jeffrey A ^a,b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; LENTIVIRUS VECTOR; MEMBRANE BOUND STEM CELL FACTOR; RECOMBINANT VASCULOTROPIN; STEM CELL FACTOR; UNCLASSIFIED DRUG;

AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENOMICS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; MOUSE; NEWBORN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION;

EID: 84871257903     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2012.063     Document Type: Article

References (40)

1. Arslan, F., de Kleijn, D.P., and Pasterkamp, G. (2011). Innate immune signaling in cardiac ischemia. Nat. Rev. Cardiol. 8, 292-300.
2. Ashman, L.K. (1999). The biology of stem cell factor and its receptor C-kit. Int. J. Biochem. Cell Biol. 31, 1037-1051.
3. Ayach, B.B., Yoshimitsu, M., Dawood, F., et al. (2006). Stem cell factor receptor induces progenitor and natural killer cellmediated cardiac survival and repair after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 103, 2304-2309.
4. Badano, L.P., Albanese, M.C., De Biaggio, P., et al. (2004). Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. J. Am. Soc. Echocardiogr. 17, 253-261.
5. Dewald, O., Zymek, P., Winkelmann, K., et al. (2005). CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96, 881-889.
6. Eisenberg, L.M., Burns, L., and Eisenberg, C.A. (2003). Hematopoietic cells from bone marrow have the potential to differentiate into cardiomyocytes in vitro. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 274, 870-882.
7. Engel, F.B., Hsieh, P.C., Lee, R.T., and Keating, M.T. (2006). FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 103, 15546-15551.
8. Ezekowitz, J.A., Kaul, P., Bakal, J.A., et al. (2009). Declining inhospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J. Am. Coll. Cardiol. 53, 13-20.
9. Frangogiannis, N.G., Perrard, J.L., Mendoza, L.H., et al. (1998). Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98, 687-698.
10. Fujii, H., Sun, Z., Li, S.H., et al. (2009). Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc. Imaging 2, 869-879.
11. Heinemann, A., Sturm, G.J., Ofner, M., et al. (2005). Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils. J. Allergy Clin. Immunol. 116, 820-826.
12. Herold, J., Pipp, F., Fernandez, B., et al. (2004). Transplantation of monocytes: A novel strategy for in vivo augmentation of collateral vessel growth. Hum. Gene Ther. 15, 1-12.
13. Higuchi, K., Ayach, B., Sato, T., et al. (2009). Direct injection of Kit ligand-2 lentivirus improves cardiac repair and rescues mice post-myocardial infarction. Mol. Ther. 17, 262-268.
14. Huang, E.J., Nocka, K.H., Buck, J., and Besmer, P. (1992). Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol. Biol. Cell 3, 349-362.
15. Jiang, X., Gurel, O., Mendiaz, E.A., et al. (2000). Structure of the active core of human stem cell factor and analysis of binding to its receptor kit. EMBO J. 19, 3192-3203.
16. Kim, C.H., and Broxmeyer, H.E. (1998). In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: Stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91, 100-110.
17. Kurosawa, K., Miyazawa, K., Gotoh, A., et al. (1996). Immobilized anti-KIT monoclonal antibody induces ligandindependent dimerization and activation of Steel factor receptor: Biologic similarity with membrane-bound form of Steel factor rather than its soluble form. Blood 87, 2235-2243.
18. Lee, C.J., Fan, X., Guo, X., and Medin, J.A. (2011). Promoterspecific lentivectors for long-term, cardiac-directed therapy of Fabry disease. J. Cardiol. 57, 115-122.
19. Lehrke, S., Mazhari, R., Durand, D.J., et al. (2006). Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ. Res. 99, 553-560.
20. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 25, 402-408.
21. Lloyd-Jones, D., Adams, R.J., Brown, T.M., et al. (2010). Heart disease and stroke statistics - 2010 update: A report from the American Heart Association. Circulation 121, e46-e215.
22. Longley, B.J., Tyrrell, L., Ma, Y., et al. (1997). Chymase cleavage of stem cell factor yields a bioactive, soluble product. Proc. Natl. Acad. Sci. U.S.A. 94, 9017-9021.
23. Lutz, M., Rosenberg, M., Kiessling, F., et al. (2008). Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-Kit + bone marrow-derived stem cells. Cardiovasc. Res. 77, 143-150.
24. Maggioni, A.P., Maseri, A., Fresco, C., et al.; Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). (1993). Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N. Engl. J. Med. 329, 1442-1448.
25. Minatoguchi, S., Takemura, G., Chen, X.H., et al. (2004). Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109, 2572-2580.
26. Miyazawa, K., Williams, D.A., Gotoh, A., et al. (1995). Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit geneencoded protein than its soluble form. Blood 85, 641-649.
27. Nahrendorf, M., Zhang, H., Hembrador, S., et al. (2008). Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 117, 379-387.
28. Orlic, D., Kajstura, J., Chimenti, S., et al. (2003). Bone marrow stem cells regenerate infarcted myocardium. Pediatr. Transplant. 7(Suppl. 3), 86-88.
29. Ren, G., Michael, L.H., Entman, M.L., and Frangogiannis, N.G. (2002). Morphological characteristics of the microvasculature in healing myocardial infarcts. J. Histochem. Cytochem. 50, 71-79.
30. Ronnstrand, L. (2004). Signal transduction via the stem cell factor receptor/c-Kit. Cell. Mol. Life Sci. 61, 2535-2548.
31. Sasajima, J., Mizukami, Y., Sugiyama, Y., et al. (2010). Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors. Cancer Res. 70, 6283-6292.
32. Sato, T., Ramsubir, S., Higuchi, K., et al. (2009). Vascular endothelial growth factor broadens lentivector distribution in the heart after neonatal injection. J. Cardiol. 54, 245-254.
33. Sun, Z., Wu, J., Fujii, H., et al. (2008). Human angiogenic cell precursors restore function in the infarcted rat heart: A comparison of cell delivery routes. Eur. J. Heart Fail. 10, 525-533.
34. Tang, X.L., Rokosh, G., Sanganalmath, S.K., et al. (2010). Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121, 293-305.
35. Trial, J., Rossen, R.D., Rubio, J., and Knowlton, A.A. (2004). Inflammation and ischemia: macrophages activated by fibronectin fragments enhance the survival of injured cardiac myocytes. Exp. Biol. Med. (Maywood) 229, 538-545.
36. Untergasser, A., Nijveen, H., Rao, X., et al. (2007). Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res. 35, W71-W74.
37. Vandervelde, S., van Luyn, M.J., Tio, R.A., and Harmsen, M.C. (2005). Signaling factors in stem cell-mediated repair of infarcted myocardium. J. Mol. Cell. Cardiol. 39, 363-376.
38. Woldbaek, P.R., Hoen, I.B., Christensen, G., and Tonnessen, T. (2002). Gene expression of colony-stimulating factors and stem cell factor after myocardial infarction in the mouse. Acta Physiol. Scand. 175, 173-181.
39. Yamamoto, T., Hartmann, K., Eckes, B., and Krieg, T. (2001). Role of stem cell factor and monocyte chemoattractant protein- 1 in the interaction between fibroblasts and mast cells in fibrosis. J. Dermatol. Sci. 26, 106-111.
40. Yau, T.M., Fung, K., Weisel, R.D., et al. (2001). Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104, I218-I222.